ZYDUS | TECHNO-FUNDA ANALYSIS

Zydus Lifesciences (1D Chart)

IMP Levels: Demand Zone: ₹920–930 Resistance Levels: ₹1,015 & ₹1,058 Company’s Business: Large pharma player — formulations, vaccines, APIs, biosimilars with strong US & India presence. Earnings: Steady YoY growth, improving margins, strong US sales recovery supporting earnings. Verdict: Price reacting well from demand zone. Reversal possible above ₹945; positive as long as ₹920 holds